Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Celularity IncCELU · Entity 7145 | President | September 15, 2021 | September 17, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Celularity Inc
Report date September 15, 2021 · Filed September 17, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.32 · Expires 2031-09-15 | Direct | 2,469,282 |
Reported balance
After 2021-09-15 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-09-15 · Grant · Acquired 2,469,282 · Balance 2,469,282 F1: This option shall vest and become exercisable in up to five installments in respect of achieving certain share price targets between the third and fourth anniversary of the effective date, September 15, 2021, subject to the Reporting Person's continuous service on each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: This option shall vest and become exercisable in up to five installments in respect of achieving certain share price targets between the third and fourth anniversary of the effective date, September 15, 2021, subject to the Reporting Person's continuous service on each vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 15, 2021 Filed Sep 17, 2021 14:48 UTC | Celularity Inc CELU · Entity 7145 | GrantStock Option (Right to Buy) · Derivative | 2,469,282 | $0.00 Strike: $6.32 | $0.00 |
DisclosureSEC source: 0001213900-21-048535 · ownership.xml · derivative · entry 1 Pecora Andrew L · CIK 0001510184 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,469,282 Underlying: Class A Common Stock · 2,469,282 shares Expires 2031-09-15 F1 · derivative.exercise_date: This option shall vest and become exercisable in up to five installments in respect of achieving certain share price targets between the third and fourth anniversary of the effective date, September 15, 2021, subject to the Reporting Person's continuous service on each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.